Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis

Item
http://www.wikidata.org/entity/Q24323164
The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosisThe Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancerMethylnaltrexone potentiates the anti-angiogenic effects of mTOR inhibitorsIncreased μ-opioid receptor expression in metastatic lung cancerκ Opioid receptor ligands regulate angiogenesis in development and in tumours.The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigationMorphine use in cancer surgeryClinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone.Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.Morphine stimulates platelet-derived growth factor receptor-β signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo.The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia.MOR1 expression in gastric cancer: a biomarker associated with poor outcome.Vascular disrupting activity and the mechanism of action of EHT 6706, a novel anticancer tubulin polymerization inhibitor.The mu opioid receptor: A new target for cancer therapy?Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.Could Perioperative Opioid Use Increase the Risk of Cancer Progression and Metastases?Perioperative Immunosuppression and Risk of Cancer Progression: The Impact of Opioids on Pain Management
P2860

Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis

Item
http://www.wikidata.org/entity/Q24323164
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Synergistic effects of methyln ...... th factor-induced angiogenesis
@ast
Synergistic effects of methyln ...... th factor-induced angiogenesis
@en
Synergistic effects of methyln ...... th factor-induced angiogenesis
@en-gb
Synergistic effects of methyln ...... th factor-induced angiogenesis
@nl
type
label
Synergistic effects of methyln ...... th factor-induced angiogenesis
@ast
Synergistic effects of methyln ...... th factor-induced angiogenesis
@en
Synergistic effects of methyln ...... th factor-induced angiogenesis
@en-gb
Synergistic effects of methyln ...... th factor-induced angiogenesis
@nl
prefLabel
Synergistic effects of methyln ...... th factor-induced angiogenesis
@ast
Synergistic effects of methyln ...... th factor-induced angiogenesis
@en
Synergistic effects of methyln ...... th factor-induced angiogenesis
@en-gb
Synergistic effects of methyln ...... th factor-induced angiogenesis
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Synergistic effects of methyln ...... th factor-induced angiogenesis
@en
P2093
P304
P31
P356
10.1158/1535-7163.MCT-07-2217
P407
P433
P478
P577
P698
P921